Tag Archive: NIH

Nov 29 2011

Fifth China Medicinal Biotech Forum – Conference Recap

I recently returned from the Fifth China Medicinal Biotech Forum held in Beijing, China from 07-09 November 2011.  The purpose of this conference was to update graduate students in China on the latest trends in biotechnology.  This forum also allowed scientists from Europe, Australia, Japan, US, and South America to collaborate with Chinese colleagues at …

Continue reading »

May 27 2011

Bridging the Valley of Death: Bringing New Drugs from the Bench to the Clinic


To bring a new medicine to the stage of clinical trial testing requires on the order of $500,000 to one million dollars and then seven to ten years of clinical trials and around $800 million dollars before getting to market.  However, it is doable, and one can point to successful biotechs such as Genentech, Amgen, …

Continue reading »

May 09 2011

Conference Recap – 2011 Society of Toxicology Annual Meeting

The Society of Toxicology’s (SOT) 50th Anniversary Annual Meeting was held on 05-10 March 2011 in Washington, DC.  Several members of Cato Research’s Nonclinical Sciences Development group were amongst the more than 7,000 toxicologists from 50 countries in attendance this year.  The five-day event provided scientists with countless opportunities to discuss the latest scientific achievements …

Continue reading »

May 05 2011

Diabetes Research Strategic Plan

The media continually alerts us to the epidemic of diabetes in the world.  Diabetes is the seventh leading cause of death.  Worldwide in 2007 there were 246 million people diagnosed with diabetes, and an additional 79 million people are at risk of developing diabetes in the near future.  According to the National Institutes of Health …

Continue reading »

Mar 10 2011

Therapeutics for Rare and Neglected Diseases – How Rare is Rare?

The U.S. National Institutes of Health (NIH) classifies a rare disease as affecting less than 200,000 individuals in the United States.  As insignificant as this classification may sound, collectively there are more than 25 million people in the United States affected by approximately 6,800 rare diseases. These rare diseases are alarmingly overlooked and under researched. …

Continue reading »

Jun 09 2010

FDA & NIH Launch Electronic Safety Reporting Portal

Biology will relate every human gene to the genes of other animals and bacteria, to this great chain of being. – Walter Gilbert The FDA and the NIH have announced a joint venture called the Safety Reporting Portal (SRP).  The SRP is a website for reporting safety data (pre- and post-market) in compliance with U.S. …

Continue reading »

Jun 01 2010

12th Annual NIH National SBIR/STTR Conference

On 02-03 June 2010, over 600 health and science managers, entrepreneurs, small business executives, university researchers, and consulting organizations will converge at the Raleigh (NC) Convention Center for the 12th Annual NIH National SBIR/STTR Conference. Attendees will learn the ins and outs of the NIH SBIR/STTR program, the funding opportunities available to small business researchers, …

Continue reading »

Apr 09 2010

White House Issues Memo on Federal Agencies and Social Media

It isn’t necessary to imagine the world ending in fire or ice. There are two other possibilities: one is paperwork, and the other is nostalgia. – Frank Zappa The White House Office of Information and Regulatory Affairs just released a memo titled:  Social Media, Web-Based Interactive Technologies, and the Paperwork Reduction Act.  Unfortunately, the title …

Continue reading »